Fisetin

What it is, the potential benefits being studied, and what the evidence supports right now.

Early human researchResearch-stage compound

01 • Start here

Potential benefits being studied.

Inflammation, frailty, and cellular-senescence hypotheses.

  • Cellular energy & aging
  • Immunity & inflammation

02 • Why it stands out

The simple explanation.

Fisetin is getting attention for inflammation, frailty, and cellular-senescence hypotheses.

03 • Research highlight

Why researchers are interested.

Early work in people makes inflammation, frailty, and cellular-senescence hypotheses the main reason to keep watching Fisetin.

Evidence detailsStudy limits, status, and safety context

Study summary: Human trials are actively testing fisetin across inflammation, frailty, and cellular-senescence questions, building on its strong laboratory research story.

What to keep in mind: Cell and animal senolytic findings do not establish an effective or safe human regimen.

Potential benefits describe research questions, not a promise that a product will produce the same result in a person.